Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Recombivax

Known as: Recombivax HB, Recombivax HBR, Recombivax-HB 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
BACKGROUND The hepatitis B surface antigen (HBsAg) has been administered over the last 20 years as a parenteral vaccine against… Expand
2005
2005
Hepatitis A and B vaccines are highly immunogenic in three-dose schedules. To obtain an equivalent result in children with two… Expand
2002
2002
  • T. Schofield
  • Developments in biologicals
  • 2002
  • Corpus ID: 23697587
Early in its development, the potency of Merck's recombinant hepatitis B vaccine, RECOMBIVAX HB, was monitored using an assay… Expand
Highly Cited
2001
Highly Cited
2001
Objectives. Hoping to increase hepatitis B (HB) vaccination of adolescents, we did the following: 1) studied if modified regimens… Expand
  • table 1
  • table 2
  • table 3
2000
2000
  • MMWR. Morbidity and mortality weekly report
  • 2000
  • Corpus ID: 12047512
Thimerosal, a mercury-based compound, is no longer used as a preservative in any of the pediatric hepatitis B vaccines licensed… Expand
1999
1999
This study was designed to assess the immunogenicity of a vaccine combining diphtheria and tetanus toxoids, acellular pertussis… Expand
1997
1997
OBJECTIVE To assess the safety, tolerability and immunogenicity of COMVAX, a liquid, bivalent Haemophilus influenzae type b… Expand
1997
1997
BACKGROUND The timing and best regimen for a booster dose of hepatitis B vaccine have not been determined. METHODS Two studies… Expand
1995
1995
A randomized trial compared the safety and immunogenicity of Engerix-B (EB) 20 micrograms administered intramuscularly (IM) at 0… Expand
1991
1991
One hundred and four healthy, hepatitis B virus (HBV) seronegative males were enrolled in a single blind, randomized pilot study… Expand